Axitinib Nitroso Impurity 4
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

Axitinib Nitroso Impurity 4

● In Stock

Catalogue No.:VE0024259
CAS No.:N/A
Mol. Formula:C15H11IN4O2S
Mol. Weight:438.24 g/mol

Additional information on Axitinib Nitroso Impurity 4

Parent drug

N/A

IUPAC Name

2-((3-iodo-1-nitroso-1H-indazol-6-yl)thio)-N-methylbenzamide

Pharmacopoeial Synonyms

N/A

Other Synonyms

N/A

Smiles

IC1=NN(N=O)C2=CC(SC3=CC=CC=C3C(NC)=O)=CC=C21

InChI

InChI=1S/C15H11IN4O2S/c1-17-15(21)11-4-2-3-5-13(11)23-9-6-7-10-12(8-9)20(19-22)18-14(10)16/h2-8H, 1H3, (H, 17, 21)

Description

Axitinib Nitroso Impurity 4 is an N-nitroso derivative of the secondary amine present | which is a highly characterized reference material that meets stringent regulatory standards set for nitrosamine compounds | including those set by USP | EMA | JP | and BP. This nitroso standard is essential for a variety of applications | such as analytical method development | method validation (AMV) | and Quality Control (QC). It is suitable for use in both Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA). This nitrosamine standard helps establish detection limits | quantify impurity levels | and ensure trace nitroso impurities in pharmaceutical products remain within FDA and EMA safety limits.

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url